Transmission and prevalence of Burkholderia cepacia in Welsh cystic fibrosis patients

Respiratory Medicine

Volumn 92, Issue 2, 1998, Pages 178-183

  Millar Jones, L ^a   Ryley, H C ^b   Paull, A ^b   Goodchild, M C ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM IDENTIFICATION; BURKHOLDERIA CEPACIA; CHILD; CROSS INFECTION; CYSTIC FIBROSIS; DISEASE TRANSMISSION; FEMALE; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RIBOTYPING; UNITED KINGDOM;

EID: 0031929065     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(98)90092-0     Document Type: Article

References (38)

1. Isles A, Maclusky I, Corey M et al. Pseudomonas cepacia infection in cystic fibrosis: An emerging problem. J Pediatr 1984; 104: 206-210.
2. Corey M, Allison L, Prober C, Levison H. Sputum bacteriology in patients with cystic fibrosis in a Toronto hospital during 1970-1981. J Infect Dis 1984; 149: 283.
3. Govan JRW, Brown PH, Maddison J et al. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 1993; 342: 15-19.
4. Thomassen MJ, Demko CA, Klinger JD, Stern RC. Pseudomonas cepacia colonisation among patients with cystic fibrosis. Am Rev Respir Dis 1985; 131: 791-796.
5. Simmonds EJ, Conway SP, Ghoneim ATM, Ross H, Littlewood JM. Pseudomonas cepacia: a new pathogen in patients with cystic fibrosis referred to a large centre in the United Kingdom. Arch Dis Child 1990; 65: 874-877.
6. Glass S, Govan JRW. Pseudomonas cepacia - fatal pulmonary infection in a patient with cystic fibrosis. J Infection 1986; 13: 157-158.
7. Lewin LO, Byard PJ, Davis PB. Effects of Pseudomonas cepacia colonisation on survival and pulmonary function of cystic fibrosis patients. J Clin Epidemiol 1990; 43: 125-131.
8. Rosenstein BJ, Hall DE. Pneumonia and septicaemia due to Pseudomonas cepacia in a patient with cystic fibrosis. Johns Hopkins Med J 1980; 147: 188-189.
9. Tomashefski JF, Thomassen MJ, Bruce MC, Goldberg HI, Konstan MW, Stern RC. Pseudomonas cepacia-associated pneumonia in cystic fibrosis. Arch Pathol Lab Med 1988; 112: 166-172.
10. Fisher MC, Lipuma JJ, Dasen SE et al. Source of Pseudomonas cepacia: Ribotyping of isolates from patients and from the environment. J Pediatr 1993; 123: 745-747.
11. Millar-Jones L, Paull A, Saunders Z, Goodchild MC. Transmission of Pseudomonas cepacia among cystic fibrosis patients. Lancet 1992; 340: 491.
12. Lipuma JJ, Dasen SE, Nielson DW, Stern RC, Stull TL. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet 1990; 336: 1094-1096.
13. Smith DL, Gumery LB, Smith EG, Stableforth DE, Kaufmann ME, Pitt TL. Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission. J Clin Microbiol 1993; 31: 3017-3022.
14. Pegues DA, Carson LA, Tablan OC et al. Acquisition of Pseudomonas cepacia at summer camps for patients with cystic fibrosis. J Pediatr 1994; 124: 694-702.
15. Taylor RFH, Dalla Costa L, Kaufmann ME, Pitt TL, Hodson ME. Pseudomonas cepacia pulmonary infection in adults with cystic fibrosis: is nosocomial acquisition occurring? J Hosp Inf 1992; 21: 199-204.
16. Burdge DR, Nakielna EM, Noble MA. Case control and vector studies of nosocomial acquisition of Pseudomonas cepacia in adult patients with cystic fibrosis. Infect Control Hosp Epidemiol 1993; 14: 127-130.
17. Rabkin CS, Jarvis WR, Anderson RL et al. Pseudomonas cepacia typing systems: Collaborative study to assess their potential in epidemiologic investigations. Rev Infect Dis 1989; 11: 600-607.
18. Govan JRW, Harris G. Typing of Pseudomonas cepacia by bacteriocin susceptibility and production. J Clin Microbiol 1985; 22: 490-494.
19. Kostmann JR, Edlin TO, Lipuma JJ, Stull TL. Molecular epidemiology of Pseudomonas cepacia determined by polymerase chain reaction ribotyping. J Clin Microbiol 1992; 30: 2084-2087.
20. Ryley HC, Millar-Jones L, Paull A, Weeks J. Characterisation of Burkholderia cepacia from cystic fibrosis patients living in Wales by PCR ribotyping. J Med Microbiol 1995; 43: 436-441.
21. Elborn JS, Shale DJ, Britton JR. Cystic fibrosis: current survival and population estimates to the year 2000. Thorax 1991; 46: 881-885.
22. Tablan OC, Chorba TL, Schidlow DV et al. Pseudomonas cepacia colonisation in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr 1985; 107: 382-387.
23. Whiteford MC, Wilkinson JD, McColl JH et al. Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak. Thorax 1995; 50: 1194-1198.
24. Hardy KA, McGowan KL, Fisher MC, Schidlow DV. Pseudomonas cepacia in the hospital setting: Lack of transmission between cystic fibrosis patients. J Pediatr 1986; 109: 51-54.
25. Taylor CJ, Howden R, Smith T, Spencer RC. Pseudomonas cepacia. Arch Dis Child 1994; 70: 358.
26. Steinbach S, LiSun MD, Jiang R, Flume P, Egan TM, Goldstein R. Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis. N Engl J Med 1994; 331: 981-987.
27. Sobel JD, Hashiman N, Reinherz G, Merzbach D. Nosocomial Pseudomonas cepacia infection associated with chlorhexidine contamination. Am J Med 1982; 73: 183-186.
28. Bassett DCJ, Stokes JJ, Thomas WRG. Wound infection with P. multivorans a waterborne contaminant of disinfection solutions. Lancet 1970; 1: 1188-1191.
29. Nelson JW, Doherty CJ, Brown PH, Greening AP, Kaufmann ME, Govan JRW. Pseudomonas cepacia in inpatients with cystic fibrosis. Lancet 1991; 338: 1525.
30. John M, Ecclestone E, Hunter E, Couroux P, Hussain Z. Epidemiology of Pseudomonas cepacia colonisation among patients with cystic fibrosis. Pediatr Pulmonol 1994; 18: 108-113.
31. Thomassen MJ, Demko CA, Doershuk CF, Stern RC, Klinger JD. Pseudomonas cepacia decrease in colonisation in patients with cystic fibrosis. Am Rev Respir Dis 1986; 134: 669-671.
32. Anon. United States Cystic Fibrosis Foundation (letter) January 1993.
33. Cystic Fibrosis Trust statement on Pseudomonas cepacia. UK Cystic Fibrosis Trust, August 1993.
34. Anon. Pseudomonas cepacia - more than a harmless commensal? (editorial). Lancet 1992; 339: 1385-1386.
35. Walters S, Smith EG. Pseudomonas cepacia in cystic fibrosis: transmissibility and its implications. Lancet 1993; 342: 3-4.
36. Nir M, Johansen HK, Hoiby N. Low incidence of pulmonary Pseudomonas cepacia infection in Danish cystic fibrosis patients. Acta Pediatr 1992; 81: 1042-1043.
37. Ryley HC, Ojeniyi B, Hoiby N, Weeks J. Lack of evidence of nosocomial cross-infection by Burkholderia cepacia among Danish cystic fibrosis patients. Eur J Clin Microbiol Infect Dis 1996; 15: 755-758.
38. Gladman G, Connor PJ, Williams RF, David TJ. Control study of Pseudomonas cepacia and Pseudomonas maltophilia in cystic fibrosis. Arch Dis Child 1992; 67: 192-195.